Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Emergent Biosolutions (NY: EBS ) 6.890 UNCHANGED Streaming Delayed Price Updated: 7:00 PM EDT, Jun 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Emergent Biosolutions < Previous 1 2 3 4 5 6 7 8 9 Next > FDA Approves Over The Counter Sale Of Opioid Reversal Drug Narcan March 29, 2023 Narcan, the prescription nasal spray that reverses opioid overdoses can now be sold over the counter (OTC), said the FDA on Wednesday, reported the NY Times, thereby authorizing a move that has... Via Benzinga Why Emergent Biosolutions Stock Is Surging Today March 29, 2023 Emergent Biosolutions Inc (NYSE: EBS) shares are trading higher Wednesday following reports the U.S. Food and Drug Administration approved the company's Naloxone nasal spray for over-the-counter use. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session March 29, 2023 Via Benzinga Why Shift Technologies Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket March 29, 2023 Gainers LogicMark, Inc. (NASDAQ: LGMK) shares rose 36.7% to $0.1914 in pre-market trading after the company reported strong revenue and margin growth for the year ended 2022. Via Benzinga Why Emergent BioSolutions Stock Is Sinking Today March 17, 2023 Investors reacted negatively to an analyst's downgrade of the healthcare stock. Via The Motley Fool Earnings Outlook For Emergent BioSolutions February 24, 2023 Via Benzinga Cal-Maine Foods, Lululemon Athletica And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session March 29, 2023 U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. Via Benzinga Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session March 17, 2023 Gainers Enzo Biochem, Inc. (NYSE: ENZ) gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp. Via Benzinga First Republic Bank, Blend Labs, Purple Innovation And Other Big Stocks Moving Lower On Friday March 17, 2023 U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Friday. Here are some big stocks recording gains in today’s session. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023 March 17, 2023 Via Benzinga Why Cassava Sciences Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket March 09, 2023 Gainers Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday March 09, 2023 It's time for another breakdown of the biggest pre-market stock movers traders will want to know about on Thursday morning! Via InvestorPlace Jim Cramer Says He's Known Novavax Is 'Worthless' For 'Very Long Time,' Trashes Company For Being Too 'Promotional' March 01, 2023 Novavax Inc (NASDAQ: NVAX) shares are crashing Wednesday after the company warned that substantial doubt exists regarding its ability to continue. Jim Cramer isn't surprised. Via Benzinga Why Emergent BioSolutions Stock Tumbled by Almost 12% Today February 28, 2023 It's not a good day for investors when their company reports a shocking plunge into the red. Via The Motley Fool Emergent BioSolutions (EBS) Q4 2022 Earnings Call Transcript February 27, 2023 EBS earnings call for the period ending December 31, 2022. Via The Motley Fool 12 Health Care Stocks Moving In Thursday's Pre-Market Session February 16, 2023 Via Benzinga Why Axcella Health Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket February 16, 2023 Gainers Axcella Health Inc. (NASDAQ: AXLA) shares rose 54.1% to $0.9290 in pre-market trading after the company announced FDA clearance of its IND application to initiate a phase 2b/3 trial in the U.S.... Via Benzinga Earnings Scheduled For February 27, 2023 February 27, 2023 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday February 16, 2023 It's time to start the day with an overview of the biggest pre-market stock movers worth keeping an eye on Thursday morning! Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's After-Market Session February 15, 2023 Via Benzinga Monkeypox Vaccine Maker Bavarian Nordic Bets $380M On Emergent Bio's Travel Vaccines February 15, 2023 Via Benzinga February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More January 31, 2023 The year has started well for biopharma companies on the regulatory front, as most decisions handed out during January were positive. The Food and Drug Administration has already cleared four new... Via Benzinga Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot January 13, 2023 Johnson & Johnson (NYSE: JNJ) has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand. Via Benzinga Stocks That Hit 52-Week Lows On Friday November 18, 2022 On Friday, 64 companies achieved new lows for the year. Via Benzinga EXCLUSIVE: SAB Biotherapeutics Posts Wider Quarterly Loss, Cash Runway Expected Into Mid-2023 November 15, 2022 SAB Biotherapeutics' (NASDAQ: SABS) Q3 net loss reached $(7.1) million, equivalent to an EPS loss of $(0.16), as compared to a net loss of $(4.1) million a year ago. Cash and cash equivalents were $8.3... Via Benzinga Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday November 15, 2022 Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus... Via Benzinga Indivior To Pay Over 100% Premium To Buy Opioid Focused Player Opiant Pharmaceuticals November 14, 2022 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session November 09, 2022 Gainers Via Benzinga 'Waiting Game Continues' In Emergent BioSolutions, Analysts Cut Price Target November 09, 2022 Via Benzinga Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday November 10, 2022 Gainers Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.